InsideArbitrage Event Driven Monitor – July 9, 2025

Merger Arbitrage

1. CRGX: The acquisition of CARGO Therapeutics, Inc. (CRGX) by Concentra Biosciences, LLC for a closing value of $170.70 million. Under the terms of the agreement, Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, plus one non-transferable contingent value right (CVR). The cash consideration of $4.379 per share represents a discount of 0.25% from the stock’s last close. (Press Release)
2. ICAD: iCAD (ICAD) announced that independent proxy advisory firms ISS and Glass Lewis have each recommended that stockholders vote “FOR” the acquisition of the company by RadNet (RDNT) at the upcoming special meeting of stockholders scheduled for July 14, 2025.
3. AKYA: The acquisition of Akoya Biosciences (AKYA) by Quanterix (QTRX) was completed on July 8, 2025. It took 179 days for the deal to be completed.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.